The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Betulinic Acid for Cancer Treatment and Prevention
Open accessAbstract
Betulinic acid is a natural product with a range of biological effects, for example potent antitumor activity. This anticancer property is linked to its ability to induce apoptotic cell death in cancer cells by triggering the mitochondrial pathway of apoptosis. In contrast to the cytotoxicity of betulinic acid against a variety of cancer types, normal cells and tissue are relatively resistant to betulinic acid, pointing to a therapeutic window. Compounds that exert a direct action on mitochondria present promising experimental cancer therapeutics, since they may trigger cell death under circumstances in which standard chemotherapeutics fail. Thus, mitochondrion-targeted agents such as betulinic acid hold great promise as a novel therapeutic strategy in the treatment of human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724
The Bcl-2 apoptotic switch in cancer development and therapy
Adams, J. M., & Cory, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210220 · Cited by 2,176
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756
Degterev, A., Boyce, M., & Yuan, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207107 · Cited by 1,107
Toxic proteins released from mitochondria in cell death
Saelens, X., Festjens, N., Walle, L. V., Gurp, M. V., Loo, G. V., & Vandenabeele, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207523 · Cited by 986
Pisha, E., Chai, H., Lee, I.-S., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A., Beecher, C. W. W., Fong, H. H. S., Kinghorn, A. D., Brown, D. M., et al. (1995) · Nature Medicine · doi:10.1038/nm1095-1046 · Cited by 886
Pharmacological properties of the ubiquitous natural product betulin
Alakurtti, S., Mäkelä, T., Koskimies, S., & Yli-Kauhaluoma, J. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.006 · Cited by 650
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 628
Cichewicz, R. H., & Kouzi, S. A. (2004) · Medicinal Research Reviews · doi:10.1002/med.10053 · Cited by 531
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
Zuco, V., Supino, R., Righetti, S. C., Cleris, L., Marchesi, E., Gambacorti-Passerini, C., & Formelli, F. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00718-2 · Cited by 530
Activation of Mitochondria and Release of Mitochondrial Apoptogenic Factors by Betulinic Acid
Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., & Debatin, K.-M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33942 · Cited by 369
Self-citationFulda, S., Friesen, C., Łoś, M., Scaffidi, C., Mier, W., Benedict, M., Núñez, G., Krammer, P. H., Peter, M. E., & Debatin, K. (1997) · PubMed · Cited by 342
Self-citationMitochondria as therapeutic targets for cancer chemotherapy
Galluzzi, L., Larochette, N., Zamzami, N., & Kroemer, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209598 · Cited by 337
Chintharlapalli, S., Papineni, S., Ramaiah, S. K., & Safe, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3735 · Cited by 297
Targeting Apoptosis Pathways in Cancer Therapy
Fulda, S., & Debatin, K.-M. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043332763 · Cited by 290
Self-citationMolecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells.
Fulda, S., Susín, S. A., Kroemer, G., & Debatin, K. (1998) · PubMed · Cited by 261
Self-citationTakada, Y., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3278 · Cited by 212
Tan, Y., Yu, R., & Pezzuto, J. M. (2003) · PubMed · Cited by 209
Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells
Fulda, S., Jeremias, I., Steiner, H. H., Pietsch, T., & Debatin, K.-M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990730)82:3<435::aid-ijc18>3.0.co;2-1 · Cited by 204
Self-citationSmith, P. F., Ogundele, A., Forrest, A., Wilton, J., Salzwedel, K., Doto, J., Allaway, G. P., & Martin, D. E. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00152-07 · Cited by 190
Betulinic acid induces apoptosis in human neuroblastoma cell lines
Schmidt, M. L., Kuzmanoff, K. L., Ling-Indeck, L., & Pezzuto, J. M. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00294-3 · Cited by 174
Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors
Fulda, S., & Debatin, K. (2000) · Medical and Pediatric Oncology · doi:10.1002/1096-911x(20001201)35:6<616::aid-mpo27>3.0.co;2-n · Cited by 157
Self-citationBetulinic acid as new activator of NF-κB: molecular mechanisms and implications for cancer therapy
Kasperczyk, H., Ferla-Brühl, K. L., Westhoff, M., Behrend, L., Zwacka, R. M., Debatin, K., & Fulda, S. (2005) · Oncogene · doi:10.1038/sj.onc.1208842 · Cited by 146
Self-citationWick, W., Grimmel, C., Wagenknecht, B., DICHGANS, J., & Weller, M. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38274-6 · Cited by 145
Betulinic acid-induced apoptosis in leukemia cells
Ehrhardt, H., Fulda, S., Führer, M., Debatin, K., & Jeremias, I. (2004) · Leukemia · doi:10.1038/sj.leu.2403406 · Cited by 135
Self-citationPaclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells
André, N., Carré, M., Brasseur, G., Pourroy, B., Kovacic, H., Briand, C. M., & Braguer, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03691-8 · Cited by 133
Chowdhury, A. R., Mandal, S., Mittra, B., Sharma, S., Mukhopadhyay, S., & Majumder, H. K. (2002) · PubMed · Cited by 131
Meng, R. D., & El‐Deiry, W. S. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5073 · Cited by 130
Yasukawa, K., Takido, M., Μatsumoto, T., Takeuchi, M., & Nakagawa, S. (2009) · Oncology · doi:10.1159/000226898 · Cited by 128
Cellular FLICE-inhibitory protein: an attractive therapeutic target?
Micheau, O. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.4.559 · Cited by 118
Betulinic acid: A new cytotoxic compound against malignant head and neck cancer cells
Thurnher, D., Turhani, D., Pelzmann, M., Wannemacher, B., Knerer, B., Formanek, M., Wacheck, V., & Selzer, E. (2003) · Head & Neck · doi:10.1002/hed.10231 · Cited by 111
Sensitization for Anticancer Drug-Induced Apoptosis by Betulinic Acid
Fulda, S., & Debatin, K. (2005) · Neoplasia · doi:10.1593/neo.04442 · Cited by 107
Self-citationSawada, N., Kataoka, K., Kondo, K., Arimochi, H., Fujino, H., Takahashi, Y., Miyoshi, T., Kuwahara, T., Monden, Y., & Ohnishi, Y. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601746 · Cited by 87
Kwon, H. J., Shim, J. S., Kim, J. H., Cho, H. Y., Yum, Y. N., Kim, S. H., & Yu, J. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01273.x · Cited by 81
Structure and Function of Aminopeptidase N
Sjöström, H., Norén, O., & Olsen, J. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46826-3_2 · Cited by 77
Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells
Fulda, S., Jeremias, I., & Debatin, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207970 · Cited by 70
Self-citationRajendran, P., Jaggi, M., Singh, M. K., Mukherjee, R., & Burman, A. C. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9081-4 · Cited by 69
Synthesis and cytotoxic activity of a-ring modified betulinic acid derivatives
You, Y., Kim, Y., Nam, N., & Ahn, B. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00724-8 · Cited by 69
Liby, K. T., Honda, T., Williams, C. R., Risingsong, R., Royce, D. B., Suh, N., Dinkova‐Kostova, A. T., Stephenson, K. K., Talalay, P., Sundararajan, C., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0180 · Cited by 61
Rieber, M., & RIEBER, M. S. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.399 · Cited by 53
Martin, D. E., Blum, R. A., Doto, J., Galbraith, H., & Ballow, C. H. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746070-00004 · Cited by 52
Selzer, E., Thallinger, C., Höeller, C., Oberkleiner, P., Wacheck, V., Pehamberger, H., & Jansen, B. (2002) · Molecular Medicine · doi:10.1007/bf03402094 · Cited by 50
Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors
Fulda, S., Jeremias, I., Pietsch, T., & Debatin, K. (1999) · Klinische Pädiatrie · doi:10.1055/s-2008-1043808 · Cited by 50
Self-citationEpinephrine absorption after different routes of administration in an animal model
Gu, X., Simons, F. R., & Simons, K. J. (1999) · Biopharmaceutics & drug disposition · doi:10.1002/1099-081x(199911)20:8<379::aid-bdd198>3.0.co;2-c · Cited by 50
Salti, G. I., Kichina, J. V., Gupta, T. K. D., Shahab Uddin, M. S., Bratescu, L., Pezzuto, J. M., Mehta, R. G., & Constantinou, A. I. (2001) · Melanoma Research · doi:10.1097/00008390-200104000-00003 · Cited by 41
Bi, Y., Xu, J., Wu, X., Ye, W., Yuan, S., & Zhang, L. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.096 · Cited by 39
Cited by
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Jäger, S., Trojan, H., Kopp, T., Laszczyk, M. N., & Scheffler, A. (2009) · Molecules · doi:10.3390/molecules14062016 · Cited by 638
Plant terpenes: defense responses, phylogenetic analysis, regulation and clinical applications
Singh, B., & Sharma, R. A. (2015) · 3 Biotech · doi:10.1007/s13205-014-0220-2 · Cited by 562
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Betulin and betulinic acid: triterpenoids derivatives with a powerful biological potential
Hordyjewska, A., Ostapiuk, A., Horecka, A., & Kurzepa, J. (2019) · Phytochemistry Reviews · doi:10.1007/s11101-019-09623-1 · Cited by 298
Metadata
- Authors
- Fulda, S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2008-06-27
- Volume
- 9
- Issue
- 6
- Pages
- 1096-1107
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2108686626
- Cited by
- 343
- References
- 50
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.